BML-210 – 5 mg

Brand:
Cayman
CAS:
537034-17-6
Storage:
-20
UN-No:
Non-Hazardous - /

Inhibition of histone deacetylase (HDAC) enzymes by compounds such as trichostatin A can have wide ranging effects in cancer, cell differentiation, and other aspects of gene expression regulation.{10663} BML-210 is a small molecule inhibitor of HDAC with an IC50 value of 30 µM when tested in HeLa cell nuclear extracts using 200 µM acetylated fluorometric substrate{14835} (substrate available in Cayman’s HDAC Activity and Inhibitor Screening Assay Kits – Item Nos. 10011563 and 10011564).  

 

Available on backorder

SKU: 10005019 - 5 mg Category:

Description

An HDAC inhibitor with an IC50 value of 30 µM when tested in HeLa cell nuclear extracts using 200 µM acetylated fluorometric substrate


Formal name: N-(2-aminophenyl)-N’-phenyl-octanediamide

Synonyms:  CAY10433|N-phenyl-N’-(2-Aminophenyl)hexamethylenediamide

Molecular weight: 339.4

CAS: 537034-17-6

Purity: ≥95%

Formulation: A crystalline solid


Product Type|Biochemicals|Small Molecule Inhibitors|Deacetylases||Research Area|Cancer||Research Area|Epigenetics, Transcription, & Translation|Erasers|Histone Deacetylation||Research Area|Neuroscience